What Labor Dr. Wisplinghoff does

Labor Dr. Wisplinghoff is a physician- and family-owned German medical diagnostic laboratory headquartered in Cologne and operating across 8 sites (Aachen, Berlin, Bonn, Delmenhorst, Frankfurt, Herne, Kempen, Schwäbisch Gmünd). Founded in 1978, the practice is organized as a GbR partnership led by three Wisplinghoff family physicians (Dr. Kurt Peter Wisplinghoff, Prof. Dr. Hilmar Wisplinghoff, and Dr. Fabian Wisplinghoff, MBA) and runs 24/7 with over 60 specialist physicians (Fachärztinnen und -ärzte) covering laboratory medicine, pathology, transfusion medicine, and human genetics. Its service portfolio spans routine clinical chemistry, hematology, immunology, serology, microbiology, and endocrinology, alongside higher-margin specialty diagnostics including NGS-based cardiogenetics and neurogenetics panels, prenatal and postnatal cytogenetics (FISH, microarray-CGH, karyotyping), tumor genetics and molecular pathology (EGFR, KRAS, BRAF, ALK, MSI), pharmacogenetics, hemato-oncology molecular monitoring, and the FDA-approved UroVysion FISH urine test for bladder cancer recurrence.

Technology is centered on validated molecular and cytogenetic platforms — PCR, FISH, next-generation sequencing, Array-CGH, and capillary electrophoresis — supported by an in-house courier sample-pickup network and the Order-Entry/LabMessenger physician integration platform for electronic test ordering and digital result transmission. Direct patient channels include the Mein Befund online results portal (meinbefund.de), the MPU driving-fitness assessment portal (mpu.wisplinghoff.de), and a set of specialized outpatient clinics (coagulation, infectious disease, environmental medicine, genetic counseling). The lab is DAkkS-accredited under DIN EN ISO/IEC 15189, is an IFCC member, and holds TÜV Rheinland certification.

The business operates two parallel revenue streams. The dominant B2B stream is fee-for-service laboratory diagnostics billed to medical practices, hospitals, and clinics through German statutory (GKV) and private (PKV) health insurance reimbursement under EBM and GOÄ schedules, with sample logistics handled by the courier fleet. A secondary D2C/IGeL stream monetizes out-of-pocket patient services including NIPT, Stockholm3 prostate cancer screening, MPU drug testing, coagulation consultations, and individual preventive packages. No external investment, parent company, or acquisition history is disclosed.

Name

Labor Dr. Wisplinghoff

Legal name

Labor Dr. Wisplinghoff, überörtliche Berufsausübungsgemeinschaft Dres. med. Wisplinghoff und Kollegen und Medizinisches Versorgungszentrum für Humangenetik und Transfusionsmedizin GbR

Website

https://wisplinghoff.de

Company type

Private

Founded year

1978

Operating status

Operating

Headcount range

501–1,000 employees

Short description

Labor Dr. Wisplinghoff is a family-owned German medical diagnostic laboratory in Cologne operating 24/7 across 8 sites with 60+ specialist physicians, providing clinical chemistry, pathology, transfusion medicine, and human genetics services to medical practices, hospitals, and direct patients nationwide.

Ownership category

akta.pro rank

Product category

Medical Diagnostic Laboratory Services

NAICS

Medical Laboratories (621511)

SIC

Services-Medical Laboratories (8071)

akta.pro primary industry

Central Laboratory Services (Core Lab Operations) (HLAGAEAA)

akta.pro secondary industries

Reference & Esoteric Testing Laboratories (HLAFAMAJ), Molecular Diagnostics & Genomics Laboratories (HLAFAMAE)

Keywords

• Medical diagnostic services
• Clinical laboratory medicine
• Human genetics diagnostics
• Transfusion medicine services
• Pathology diagnostics

Headquarters

HQ city

Köln

HQ country

Germany

HQ region

Europe

Offices9 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Supply Chain, Marketing or Sales

Revenue model

1. B2B Laboratory Diagnostic Services: Laboratory testing services billed to medical practices, clinics, and hospitals. Revenue generated through statutory health insurance (GKV/gesetzliche Krankenversicherung) and private insurance (PKV/privat Krankenversicherung) reimbursement according to EBM and GOÄ fee schedules.
2. Patient-Direct Services (IGeL): Individual health services offered directly to patients including NIPT (non-invasive prenatal testing), Stockholm3 prostate cancer screening, MPU drug testing, and preventive health packages. Billed privately to patients.

Pricing tiers

Go-to-market motion2 records

Distribution channels3 records

Marketing channels6 records

Core offering

Physician- and family-owned medical diagnostic laboratory providing comprehensive clinical laboratory medicine, pathology, transfusion medicine, and human genetics services across 8 locations in Germany. Over 60 specialist physicians operate 24/7 to deliver diagnostic testing to medical practices, hospitals, and clinics, supplemented by direct patient services including NIPT, MPU testing, coagulation consultation, and genetic counseling.

Product overview

Labor Dr. Wisplinghoff is a physician- and family-owned medical diagnostic laboratory offering the full spectrum of laboratory medicine, pathology, transfusion medicine, and human genetics across 8 German locations (Cologne main site plus Aachen, Berlin, Bonn, Delmenhorst, Frankfurt, Herne, Kempen, and Schwäbisch Gmünd). The portfolio centers on four core disciplines — laboratory medicine diagnostics (clinical chemistry, hematology, immunology, microbiology, serology, endocrinology, toxicology), pathology/cytology (including molecular pathology), transfusion medicine/blood depot, and human genetics (molecular genetics, cytogenetics, pharmacogenetics, genetic counseling). These are flanked by specialized add-on services including NIPT (non-invasive prenatal testing, offered since 2015), the Stockholm3 prostate cancer screening test, an MPU portal for driving-ability assessments, the Mein Befund online patient results portal (meinbefund.de), a coagulation outpatient clinic, and an infectious disease private outpatient clinic. The laboratory employs over 60 specialist physicians and operates 24/7. Sample logistics are supported by a laboratory-owned pickup service, and the online Order-Entry system (LabMessenger) enables electronic test ordering by physicians.

Differentiator

Problem solved

Functional benefit

Brands

• Mein Befund: Online patient portal for accessing laboratory results digitally
• HYGIUM
• MPU Portal

Products and services

• Laboratoriumsmedizin (Laboratory Medicine Diagnostics) Core laboratory diagnostics covering clinical chemistry, hematology, coagulation, immunology, serology, endocrinology, microbiology, and infectious disease testing for medical practices and hospitals.
• Pathologie / Zytologie (Pathology / Cytology) Histological and cytological pathology analysis for medical practices and hospitals, including specialized molecular pathology techniques such as UroVysion FISH testing for bladder cancer detection.
• Transfusionsmedizin (Transfusion Medicine / Blood Depot) Transfusion medicine and blood depot services including immunohematology and blood group diagnostics for hospitals and clinics.
• Humangenetik (Human Genetics) Comprehensive human genetic diagnostics including molecular genetics, cytogenetics, microarray-CGH, and non-invasive prenatal testing (NIPT) for medical practices and patients.
• NIPT (Non-Invasive Prenatal Test) Non-invasive prenatal blood test for genetic screening of fetal chromosomal abnormalities, offered directly to pregnant patients.
• Stockholm3-Test Blood-based screening test for early detection of prostate cancer, offered as a specialized diagnostic service.
• MPU (Medizinisch-Psychologische Untersuchung) Medizinisch-Psychologische Untersuchung (driving ability assessment) laboratory diagnostics delivered through a dedicated online portal for individuals and assessment centers.
• Gerinnungsambulanz (Coagulation Outpatient Clinic) Specialized outpatient consultation service for coagulation disorders and thrombosis patients.
• Humangenetische Beratung (Genetic Counseling) Personal genetic counseling service provided to patients on hereditary disease risks, family planning, and diagnostic findings.
• Individuelle Vorsorge / IGeL (Individual Preventive Health Services) Individual preventive health services (IGeL-Leistungen) provided directly to patients on a self-pay basis, outside of statutory health insurance coverage.

Quantifiable outcome

• 24/7 laboratory operations ensuring continuous diagnostic availability
• +1 more outcomes

Named customers3 records

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature8 records

Partnerships

Three partnerships are on record, tiered core and minor.

• NAK (Nationales Antibiotika-Sensitivitätstest-Komitee)coreTechnology or IntegrationMembership and adherence to EUCAST (European Committee on Antimicrobial Susceptibility Testing) standards for antibiotic sensitivity testing. Provides resistance testing guidelines and antibiotic dosing recommendations for adolescents and adults.
• DAkkS (Deutsche Akkreditierungsstelle GmbH)coreOthersAccreditation body providing official recognition of laboratory competence according to DIN EN ISO/IEC 15189 standards
• IFCC (International Federation of Clinical Chemistry and Laboratory Medicine)minorOthersInternational professional organization for clinical chemistry and laboratory medicine

Scale indicators5 records

Recent moves5 records

Expansion highlights5 records

Direct peers

• Synlab: Europe's largest medical diagnostics provider operating a national network of routine and specialty labs across Germany, directly comparable to Wisplinghoff's full-service B2B and specialty testing model.
• LADR Der Laborverbund Dr. Kramer & Kollegen: Physician-led regional laboratory network in northern Germany offering comparable routine and specialty diagnostics to practices and clinics — the closest mid-sized, physician-owned peer to Wisplinghoff.
• MVZ Labor Limbach: Specialty-focused German laboratory group with broad routine and esoteric testing, similar multi-site footprint and B2B/hospital channel mix as Wisplinghoff.
• amedes Genetics: German specialty lab (part of amedes group) focused on human genetics, reproductive medicine, and gynecology-endocrinology — overlaps directly with Wisplinghoff's NIPT, cytogenetics, and pharmacogenetics services.

Broad incumbents

• Sonic Healthcare Germany: Subsidiary of global diagnostics giant Sonic Healthcare, operating multiple German labs (including former Bioscientia) — competes in routine and specialty testing at greater scale.
• Unilabs: Pan-European diagnostics chain (A.P. Møller Holding) with a presence across multiple European countries including Germany — comparable in offering breadth but with much greater geographic and scale reach.
• Helios Laboratory Services (Fresenius): Hospital-affiliated lab network operated by Helios/Fresenius serving inpatient and outpatient diagnostics — a partial competitor for hospital tenders and clinical chemistry volume.

Others

• Medicover Genetics / GenePlanet:

Market position

Strengths3 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/wisplinghoff
• LinkedInlinkedin.com/company/wisplinghoff

Revenue estimate

Valuation estimate

Number of profiles

Profiles8 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Labor Dr. Wisplinghoff